Monarch Partners Asset Management LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
Monarch Partners Asset Management LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2022$3,226,000
+114.6%
674,845
+195.8%
0.97%
+348.6%
Q2 2021$1,503,000
+99.9%
228,125
+145.9%
0.22%
+91.2%
Q1 2021$752,000
+9.8%
92,780
-12.6%
0.11%
-5.8%
Q4 2020$685,000
+61.6%
106,165
-9.8%
0.12%
+26.3%
Q3 2020$424,000
+15.5%
117,645
+47.6%
0.10%
+5.6%
Q2 2020$367,00079,7250.09%
Other shareholders
IMMUNOGEN INC shareholders Q4 2020
NameSharesValueWeighting ↓
QVT Financial LP 1,375,900$6,329,0001.08%
Redmile Group, LLC 12,006,979$55,232,0001.02%
Birchview Capital, LP 190,000$874,0000.53%
Fernwood Investment Management, LLC 179,340$825,0000.41%
HealthCor Management, L.P. 1,200,000$5,520,0000.23%
Grace Capital 49,500$228,0000.20%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$479,0000.19%
Virtus ETF Advisers LLC 79,795$367,0000.17%
PINNACLE ASSOCIATES LTD 1,087,034$5,000,0000.12%
HUSSMAN STRATEGIC ADVISORS, INC. 100,000$460,0000.12%
View complete list of IMMUNOGEN INC shareholders